News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Theratechnologies
< Previous
1
2
Next >
Theratechnologies Announces Pricing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement
October 26, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Announces Proposed Public Offering of Common Shares and Concurrent Private Placement
October 25, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Announces Operational Update
October 24, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies’ Ibalizumab Demonstrates Cost-Effectiveness as an Addition to Routine Clinical Care in Heavily Treatment-Experienced People with HIV
October 19, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Announces Finalization of Amendments to Some of the Terms and Conditions of its Credit Agreement with Marathon
October 16, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Presents Data at ID Week Showing Tesamorelin Reduces Visceral Adipose Tissue (VAT) and Liver Fat in People with HIV on Integrase Inhibitors (INSTIs)
October 13, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Announces Results from Trogarzo® (Ibalizumab-uiyk) Intramuscular Administration Study
October 13, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Announces Dosing of First Patient in Updated Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
October 12, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Receives January 2024 PDUFA Goal Date for Tesamorelin F8 Formulation sBLA
October 04, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
September 26, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility
September 25, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Submits Tesamorelin F8 Formulation sBLA for FDA Review
September 25, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
September 20, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update
September 18, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 07, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Announces Certain Preliminary Q3 2023 Financial Highlights
September 05, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Announces All U.S. Oncology Clinical Sites Now Enrolling for Phase 1 Trial of Sudocetaxel Zendusortide
August 30, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Completes 1-for-4 Reverse Stock Split
July 31, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Announces Amendments to its Term Loan Facility With Affiliates of Marathon Asset Management
July 28, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Announces the Resignation of One of Its Directors, Mr. Gary Littlejohn
July 21, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Announces 1-for-4 Reverse Stock Split
July 20, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Reports Second Quarter 2023 Financial Results and Business Updates
July 12, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies to Announce Second Quarter 2023 Financial Results and Provide Business Update
June 29, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Draws Down on US$20 Million Second Tranche Under its Term Loan Facility With Affiliates of Marathon Asset Management
June 22, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies June 13 Oncology Investigator Call to Update Investors & Analysts on Phase 1 Sudocetaxel Zendusortide Trial
June 12, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
June 02, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies to Present Preliminary Safety and Efficacy Data from Phase 1 Trial of Sudocetaxel Zendusortide in Heavily Pretreated Cancer Patients at ASCO 2023
May 25, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Reports on its Annual Meeting of Shareholders
May 09, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies’ Trogarzo® (Ibalizumab-uiyk) Shortens Time to HIV Undetectability and Extends Durability of Undetectability and Viral Suppression in a Matched Treatment Comparison
May 04, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Theratechnologies Data Presentations at AACR 2023 Showcase Potential of Sudocetaxel Zendusortide as a Single Agent and in Combination with other Anticancer Therapies
April 18, 2023
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close